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STRONTIUM METABOLISM IN THE REBUILDING
OF SKELETAI, TISSUE
Bone density studies on the crewmen of the Skylab 3 anti 4 missions showed
varying degrees of bone mineral loss upon exposure to a weightless environment.
Baylink and Holton (1) demonstrated in rats that the mlraral loss may be due to
a cessation of hone formation and that postflight bone formation increased dram-
atically to correct the defect in a relatively short period of tithe. Opera' ing on
the idea of a rapid postflight rebuilding of bone, Palmer and Karagianes (2) sought
to measure the rate of bone mineral uptake following immobilization with the use
r	 r
of a radioactive bone mineral tracer, strontium 85 ( 85Sr). 8`'Sr is a pure gamma
emitter with a half-life of 65 days. These characteristi. a make it well Fuited for
external counting techniques. It is used in lieu of the calcium isotopes because
the calcium isotopes cannot penetrate the tissue depth or have too short of a half-
life for adequate study.
Evidence of the relationship between strontium and calcium kinetics has
r	 r
been most extensively studied by Spencer. Oral doses of 85 Srand 45 Caresult
in high feca: and low urinary levels of both tracers, (3 ' 4) Intravenous injections
of the strontium and calcium yield high urinary and low fecal levels of both
tracers. (3) In every case the amount of strontium is higher than that of calcium
with the l evel being 20 to 30% higher in fecal samples of oral doses, and approx-
imately 15% higher in urine samples of intravenous doses, (3) The conclusions
drawn from these studies are that, 1) strontium is not absorbed by the gastro-
intestinal tract as well as calcium, and 2) it is excreted In higher quantities
than calciwn by the kidney. The result is a significantly lower concentration
of strontium in the tissues of the body, especially under oral administration.
The strontium that enters the body, though, appears to have the same plasma
kinetics as calcium (Figure 1 and 2). To further examine strontium and plasma
kinetics, chemical agents modifying the tracer excretion rates were studied.
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The removal of strontium and calcium in men under both short and long
term exposure periods was examined using high and low levels of calcium,
strontium, ammonium chloride, and magnesium. The removal of radiostron-
tium from the body, immediately upon exposure, is basically removal from the
blood via the kidneys. The agents effect the removal at the site of the kidney
itself. This is evidenced by the differing patterns of calcium and strontium
urinary excretions and the lack of differences in fecal and plasma levels from
control.	 The removal of radiostrontiuni two or more weeks after expo-
sure is believed to be removal from the bone. The calcium dietary intake
showed little to no effect upon calcium and strontium excretion. (7) A low cal-
cium dietary intake in conjunction with ammonium chloride, though, produces
increased and identical patterns of calcium and strontium urinary excretiog:' 7)
Magnesium, calcium, ( ' )
 and strontium (8) infusions also result in similar and
higher losses of calcium and strontium excretion. These results indicate that
with exception of the GIT and kidney, calcium and strontium metabolism are
very similar.
Since calcium Is mainly a bone mineral, the site of strontium activity
would also be expected to be at the bone. Strontium has aeen used as a calcium
mimetic to study skeletal metabolism, both for research (9, 10) and clinical
purposes. (11,12) Direct examinations of strontium metabolism upon bone show
that lanthanum, an inhibitor of calciwn deposition, is also an inhibitor of stron-
tiumdeposition. (13) Vitamin 1) has similar effects on strontium and calcium in
the deposition of the inincrals in bone. 	 Calcium content was higher than
strontium in the tibia of the rat by about 30%, but strontium and calcium plasma
concentrations were found to be equivalent. This indicates that there may be a
discrimination at the site of the bone as well, but that the discrimination is not
so great as to effect plasma concentrations. The discrimination appears to be
a function of size differences between the strontium and the calcium in the
crystallization of hydroxyapatite. (15) In the amorphous stage of bon!. formation
4strontiun ,
 is readily incorporated into the bone, but as crystallization occurs,
the larger strontium is eliminated and replaced by the calcium. Strontium
deposition, therefore, will yield a qualitative measurement of the distribution
of bone mineral less and the proportionality of those losses as they are distin-
guished throughout the body by the rebuilding of the demineralized bone.
Procedure
The experimental plan is based upon a preflight and a postflight compari-
son of the accumulation of 85 Sras detected by the whole-body counter located
in the Low Level Radiation Counting Laboratory at JSC. The lahoratory con-
tains the lowest level of radioactive background in the free world. A preflight,
or control, study will begin at least 5 weeks before the flight while the experi-
mental study will start the first day postflight. Immediately prior to the begin-
ning of the postflight experiment, a whole-body scan and a plasma sample will
be taken to measure pre-existing 85 Sr counts and concentrations in the body.
The preflight study will require a 1. 0 juCi/kg body weight dose of 85 Sr>f
to be injected intravenously. Plasma samples of 2.0 nls will be collected 30
minutes after the injection and every 72 hours thereafter, in the morning while
r
the subject is in the post-absorptive state. The 85 Srbecomes distributed in
the body and initially falls rapidly in concentration. The purpose of the plasma
sampling is to maintain a measure of the 8-1) Sr distributed throughout the body
fluids. Plasma radio-activity will be measured by a scintillation counter and
will be recorded in terms of percent administered dose.
Immediately following the collection of plasma samples, a whole-body
scan using a whole-body counter will measure the number of radioactive counts
and the location of the counts in the body. The readings will be taken at an
energy range of 0. 44 to 0.58 Me V, 0. 51 MeV being the preferred value. As
r
the time following injection increases the amount of 85 Srin the body fluids
will decrease rapidly while the amount localized in the bones will stabilize or
h
5decrease gradually. Two phases of mineral metabolism will he occurring.
One, anti the more rapid of the two, is surface activity, a rapid exchange of
the isotope in plasma with bone. The second, of which this study concerns
Itself with, is the focal uptake of 85 Srin areas of new bone formation. Sur-
face activity occurs mainly in the early phase anti appears to have little influ-
ence by 7 days. By around 7 days the tracer is largely incorporated into areas
of new bone formation, (16) probably as amorpraous bone, then crystallized bone.
Therefore, in the preflight analysis, a qualitative measurement of bone forma-
lion will be derived during a given perioti of time.
The measurements will be taken for a period of 16 days as previously
described. An estimation of bone formation rate will be determined from a
graph showing the relative bone and plasma activity levels as a function of
time. The value will be in terms of the percent administered dose located in
the bone (at a specific site or as a whole) at a particular elapsed time period.
The time period chosen will depend upon the values of the body counts and
plasma counts, probably around 7 days post injection.
The same procedures will be followed in the postflight experiment.
Because of the expected jump in bone formation activity at the site of demin-
eralization, a rapid and large uptake of 85 Srsh-)uld occur at those sites.
They should be distinct by around the 7th day after the injection. The results
should manifest themselves as localized areas of higher specific activity,
85
higher number of Sr counts, and consequently a higher estimation of bone
formation rate when compared to the preflight values. A comparison of the
pre- and postflight areas of localized specific activity should also give an
indication of the type of bone that is demineralized during exposure to zero-g.
Of particular interest is the resciution of whether demineralization occurs in
high stress related bones, throughout the body, or only in leg bones. This
type of information will be instrumental in dirrscting the theories and type of
research to be foll"ved in the future.
..d.
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Fundamental to the study then are the assumptions that the 85 SrwiII be
distributed evenly throughout the body, that all areas of bone %% , III be equally
r
exposed to the 85 Srso that an equal opportunity of 85 Sr deposition will be
available to all sites undergoing rebuilding, and that those whole-body scan-,
considered to have negligible plasma counts « , ill be interpreted as 85 Srbone
contents.
Under the procedures outlined above, the calculated, strontium radiation
dose to an adult human would be 88 mrem to the skeleton and 46 mrem to the
whole-body. A single µCi Injection of 85 Srwould be approximately 44 mrem
and 23 mrem, respectively. (2) Such doses are well below the recommended
maximum radiation exposure levels for experimental subjects. (17)
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